Previously evidence has demonstrated that as-needed combination low-dose budesonide-formoterol reduced the risk of severe exacerbations compared with short-acting β2-agonist (SABA) reliever therapy in an adolescent with mild asthma. Concerns as if the extra benefit offered by this drug outweighs the additional cost. This study aimed to evaluate the cost-effectiveness of as-needed combination low-dose budesonide-formoterol compared with short-acting β2-agonist (SABA) reliever therapy in adolescents with mild asthma in Colombia.

中文翻译：

---

青少年轻度哮喘按需联合低剂量布地奈德-福莫特罗的成本-效用

先前的证据表明，按照需要组合低剂量布地奈德-福莫特罗减少了与短效相比严重恶化的风险β在轻度哮喘青少年2激动剂（SABA）缓解治疗。担心这种药物提供的额外好处是否超过了额外成本。本研究的目的是评估与短效相比，需要的组合低剂量布地奈德-福莫特罗的成本效益β与在哥伦比亚轻度哮喘青少年2激动剂（SABA）缓解治疗。